[Carbidopa-levodopa, growth hormone and parkinsonism].
作者信息
Marti-Masso J F, Carrera N, Martínez-Lage J M
出版信息
Rev Clin Esp. 1976 Jun 30;141(6):525-32.
PMID:968087
Abstract
摘要
相似文献
1
[Carbidopa-levodopa, growth hormone and parkinsonism].[卡比多巴-左旋多巴、生长激素与帕金森病]
Rev Clin Esp. 1976 Jun 30;141(6):525-32.
2
[Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
Clin Ter. 1975 Aug 15;74(3):265-70.
3
Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.金刚烷胺与卡比多巴和左旋多巴固定复方用于帕金森病：初步报告。
Curr Ther Res Clin Exp. 1976 Mar;19(3):337-8.
4
[The clinical experience with the decarboxylase-blocked levodopa (Nacom) in the Parkinsonism patients].[帕金森病患者使用脱羧酶阻断型左旋多巴（Nacom）的临床经验]
ZFA (Stuttgart). 1976 Mar 10;52(7):380-8.
5
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
Aust N Z J Med. 1974 Aug;4(4):373-8. doi: 10.1111/j.1445-5994.1974.tb03207.x.
6
[Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].[卡比多巴-左旋多巴疗法（息宁）治疗帕金森病患者。4年治疗结果]
Arch Neurobiol (Madr). 1978 Jan-Feb;41(1):3-18.
7
Sinemet.息宁
Drug Ther Bull. 1974 Oct 11;12(21):83-4.
8
[Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].左旋多巴与多巴脱羧酶抑制剂治疗帕金森病
Neurol Neurocir Psiquiatr. 1976;17(4):293-300.
9
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.左旋多巴与脱羧酶抑制剂：其临床药理学及在帕金森病治疗中的应用综述
Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001.
10
[Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].左旋多巴与卡比多巴联合治疗帕金森综合征
Arch Invest Med (Mex). 1977;8(2):123-8.
Zotero 插件